Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116422207 | 11642220 | 7 | F | 20150930 | 20160824 | 20151019 | 20160905 | EXP | US-PFIZER INC-2015334364 | PFIZER | 71.00 | YR | M | Y | 93.42000 | KG | 20160905 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116422207 | 11642220 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 116422207 | 11642220 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | Y | 21938 | CAPSULE, HARD | |||||||||
| 116422207 | 11642220 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 116422207 | 11642220 | 4 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 5 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 7 | C | COZAAR | LOSARTAN POTASSIUM | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 8 | C | FISH OIL | FISH OIL | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 9 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 11 | C | LUMIGAN | BIMATOPROST | 1 | UNK | 0 | EYE DROPS | ||||||||||
| 116422207 | 11642220 | 12 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 13 | C | GLUCOSAMINE CHONDROITIN | CHONDROITIN SULFATE (BOVINE)GLUCOSAMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116422207 | 11642220 | 14 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116422207 | 11642220 | 1 | Renal cancer stage IV |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116422207 | 11642220 | HO |
| 116422207 | 11642220 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116422207 | 11642220 | Arthralgia | |
| 116422207 | 11642220 | Asthenia | |
| 116422207 | 11642220 | Blood creatinine increased | |
| 116422207 | 11642220 | Body temperature increased | |
| 116422207 | 11642220 | Dehydration | |
| 116422207 | 11642220 | Diarrhoea | |
| 116422207 | 11642220 | Dysgeusia | |
| 116422207 | 11642220 | Dysstasia | |
| 116422207 | 11642220 | Epistaxis | |
| 116422207 | 11642220 | Gastric disorder | |
| 116422207 | 11642220 | Gastric perforation | |
| 116422207 | 11642220 | Haematochezia | |
| 116422207 | 11642220 | Hyperkeratosis | |
| 116422207 | 11642220 | Inflammation | |
| 116422207 | 11642220 | Nasopharyngitis | |
| 116422207 | 11642220 | Pain | |
| 116422207 | 11642220 | Pain in extremity | |
| 116422207 | 11642220 | Platelet count decreased | |
| 116422207 | 11642220 | Sinus disorder | |
| 116422207 | 11642220 | Vomiting | |
| 116422207 | 11642220 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116422207 | 11642220 | 1 | 20150917 | 20151003 | 0 | |
| 116422207 | 11642220 | 2 | 20151007 | 20151225 | 0 | |
| 116422207 | 11642220 | 3 | 20160101 | 20160811 | 0 |